<DOC>
	<DOCNO>NCT00951418</DOCNO>
	<brief_summary>This study aim investigate relationship serum level clozapine cognitive performance patient ICD-10 Schizophrenia treat clozapine monotherapy . The hypothesis high serum level clozapine associate cognitive dysfunction . Furthermore , ECG change relation serum level clozapine study . The design cross-sectional .</brief_summary>
	<brief_title>Serum Clozapine Cognition</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>Treated clozapine minimum 6 month . Fixed dosage clozapine last month inclusion . Substance misuse . Depression ( Calgary Depression score â‰¥7 ) . Somatic disease interfere cognitive performance . Treatment benzodiazepine ( halflives &gt; 15 hour allow 14 day prior inclusion study . Halflives &lt; 15 hour allow 3 day prior cognitive test ) . Electroconvulsive therapy . Treatment antipsychotic . Withdrawal inform consent . Compulsory measure . Treatment anticholinergic except atropine drop administer sublingually . Changes use tobacco last month inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>clozapine</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>cognition</keyword>
	<keyword>t-wave morphology</keyword>
</DOC>